Iolanda Jordán García
Investigador
Research line:
Immunological dysfunction and diagnostic technology in pediatric critical care patients
Researcher Iolanda Jordan graduated in Medicine in 1994 from the University of Barcelona and received his Doctor of Medicine and Surgery degree from the University of Barcelona in 2004. Currently doing master's degree in management Universitat de Barcelona, 2021-2023.
Professor at Barcelona University and in 2 Masters, since 2008. She is senior staff of the Hospital Sant Joan de Déu Pediatric Intensive Care Unit since 2002 and Deputy Medical Director since 2021. Infectious diseases are her field of research. Immediately after the PhD the research was done in the Infectious Disease Research Group from the Institut de Recerca Sant Joan de Déu, being the coordinator PI and leader of the biomarkers and inflammatory response in this group, since 2007.
Currently leader of the "Immunological dysfunction and diagnostic technology in pediatric critical care patients", of the PICU research group and the principal investigator of the "Nosocomial Infection Research Team".
Doctor is also collaborator investigator in the Consortium for Biomedical Research in Epidemiology and Public Health Network (CIBERESP), since 2016; and collaborator investigator in the consolidated group of Research (University and Research Grants Management Agency AGAUR), Generalitat de Catalunya 2017 / SGR / 742, since 2010.
Iolanda Jordan is researcher in the Translational Research Network in pediatric infectiology, belonging to network 1 of the European research network of the European Media Agency, since 2018.
Since the pandemic on March 2020, PI of the Pediatrics' research line in the Kids Corona Platform, achieving national and international collaborations (like the one with the research group "COVID Human Genetic Effort" leaded by The Rockefeller University).
Participation in more than 25 projects since 2007, as PI and collaborator, most of them in relation with infectious disease, inflammatory response, and biomarkers; with private and public competitive funding.
She has achieved more than 160 publications (ORCID 0000-0002-2041-4425), over 20 research projects (6 competitive grants), leader of 4 multicenter studies, and collaborator in 10 international projects. Her translational research has led to the design and validation of 3 infectious severity clinical scores, and to define the biomarkers impact and algorithmic application in severe and critical ill patients. PI was awarded with the "Award for professional excellence from the Barcelona Medical College" in 2017.
PI also has an active participation in professional and community diffusion activities (radio, television, newspapers) and is usually invited to talks (21 in the last 5 years). She also collaborates as assessor to the Health Department of the Catalonia Government and with the National Health Ministry for the COVID management in pediatrics, among others.
Professional network profiles
Related websites
Last Publications
- Alejandre-Galobardes C, Penela-Sánchez, D, Alsina, J, Agüera, M, Soler-García a, Moussalam, S, Munoz-Almagro C, Brotons-de los Reyes P, Cambra-Lasaosa FJ, Forner, OR, Balaguer-Gargallo M, Launes-Montana C and Jordán-García I Impact of universal immunization program with monoclonal antibody nirsevimab on reducing the burden of serious bronchiolitis that need pediatric intensive care. EUROPEAN JOURNAL OF PEDIATRICS . 183(9): 3897-3904.
- Peña-López Y, Slocker-Barrio M, de-Carlos-Vicente JC, Serrano-Megías M, Jordán-García I and Rello J Outcomes associated with ventilator-associated events (VAE), respiratory infections (VARI), pneumonia (VAP) and tracheobronchitis (VAT) in ventilated pediatric ICU patients: A multicentre prospective cohort study. INTENS CRIT CARE NUR . 83: 103664-103664.
- Pons-Tomas, Gemma, Hernandez-Garcia, Maria, Mele-Casas, Maria, Fernández de Sevilla-Estrach M, Launes-Montana C, Girona M, Rios-Barnés M, Bassat Q, Ajanovic, Sara, Cubells M, Claverol J, Penela-Sanchez, Daniel, Jou-Munoz C, Manuel Monsonis Cabedo, Esteva-Afonso C, Fassanella, Assumpta, Cuadras-Palleja D, Munoz-Almagro C, Jordán-García I, Fortuny-Guasch C, García-García JJ and Fumadó V Clinical Characterization, Transmissibility, and Seroconversion of SARS-CoV-2 Infection in Children (before the Start of Vaccination) in the Barcelona Metropolitan Region (Spain) Journal of Pediatric Infectious Diseases . : .
Projects
- Project name:
- Desarrollo, validación y prueba piloto de modelos basados en aprendizaje automático para predicción y detección temprana de sepsis en Urgencias e intensivos pediátricos. Proyecto PESERS 2.0
- Leader
- Iolanda Jordán García
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI23/00055
- Starting - finishing date:
- 2024 - 2026
- Project name:
- SGR 2022-2024_Enfermedades Infecciosas en la Edad Pediátrica y Microbioma
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 00396
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Estudio multicéntrico fase 2 en pacientes pediátricos (0-18 años) con leucemia linfoblástica aguda B CD19+ en recaída o refractaria
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI21/00033
- Starting - finishing date:
- 2022 - 2025
News
-
Relationship of environmental exposure to nitrogen oxide with the severity of rhinovirus infection
Researchers at Institut de Recerca Sant Joan de Déu (IRSJD) · SJD Barcelona Children's Hospital have found that exposure to higher concentrations of atmospheric nitrogen oxide in childhood is associated with greater severity of rhinovirus infection and a higher number of admissions to the Paediatric Intensive Care Unit.
-
Researchers discover a key factor that predicts COVID-19 disease severity
A study led by Drs. Laia Alsina and Iolanda Jordan from the IRSJD evidences a key factor that predicts the severity of COVID-19: an alteration of the first immune response to SARS-CoV-2 infection, in key molecules in the anti-infective response. The study has been published in open access in the journal iScience.
-
Measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections
A study, published in BMC Medicine, performed through the Kids Corona platform from Sant Joan de Déu in collaboration with ISGlobal, shows that measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections.